Concepedia

16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD-L1-selected non-small cell lung cancer (NSCLC)

Benjamin Besse, Melissa Johnson, P.A. Jänne, Marina Chiara Garassino, Wilfried Eberhardt, Benjamin Besse, Melissa Johnson, P.A. Jänne, Marina Chiara Garassino, Wilfried Eberhardt,

European Journal of Cancer · 2015 · 72 citations · 0 references

Concepts

MedicineOncologyPharmacologyMedical OncologyMetastasisThoracic OncologyCancer ImmunotherapyLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsTargeted Cancer TherapyTargeted TherapyAtezolizumab TherapyNon-small Cell Lung Cancer ImmunotherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPhase Ii InvestigationSingle-arm Trial EvidenceSingle-arm Trials